Research Topics
Genomes and Genes | Dick de ZeeuwSummaryAffiliation: University Medical Center Groningen Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomyWillemijn A K M Windt
Department of Clinical Pharmacology, Groningen Institute for Drug Evaluation GUIDE, University Medical Center Groningen, Antonius Deusinglaan 1 NL 9713 AV Groningen NL 9713, The Netherlands
J Renin Angiotensin Aldosterone Syst 7:217-24. 2006....
Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational studyJacoba P Greving
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands
Cardiovasc Diabetol 6:25. 2007..The objective is to assess trends in risk factor treatment, and identify determinants for medication adjustments in patients with uncontrolled hypertension and/or hyperlipidemia...
Renal disease: a common and a silent killerDick de Zeeuw
Department of Clinical Pharmacology, University Medical Center, Groningen, The Netherlands
Nat Clin Pract Cardiovasc Med 5:S27-35. 2008....
Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?Dick de Zeeuw
Department of Clinical Pharmacology, University Medical Center, Groningen, The Netherlands
Nat Clin Pract Cardiovasc Med 5:S10-4. 2008..The syndrome has, however, served and continues to serve a useful purpose in raising awareness of the metabolic consequences of obesity, and as a spur for research into metabolic risk factor interactions...
Microalbuminuria as an early marker for cardiovascular diseaseDick de Zeeuw
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Am Soc Nephrol 17:2100-5. 2006..In conclusion, albuminuria seems to be a sensitive marker very early in life for the susceptibility of an individual to CV disease. It therefore may be an ideal target for early primary prevention using CV-protective therapy regimens...
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialDick de Zeeuw
University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
Lancet 376:1543-51. 2010..We aimed to assess whether paricalcitol could be used to reduce albuminuria in patients with diabetic nephropathy...
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAALD de Zeeuw
Department of Clinical Pharmacology, Groningen University Medical Center, Groningen, The Netherlands
Kidney Int 69:1675-82. 2006..Since the RENAAL study was not powered to determine ethnic responses, these results underline the need for prospective trials where the aim is renal protection among different ethnic groups...
Unmet need in renal protection--do we need a more comprehensive approach?Dick de Zeeuw
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Contrib Nephrol 171:157-60. 2011..Recent trials testing the effect of vitamin D receptor activators and the effect of statins indicate that drugs in these classes may become valuable extra tools (in addition to ACEi or ARB) to tackle the unmet need in renal protection...
Albuminuria: a great risk marker, but an underestimated target in diabetesDick de Zeeuw
Department of Clinical Pharmacology, University Medical Center Groningen, Sector F, PO Box 169, 9700 AD Groningen, The Netherlands
Diabetes Care 31:S190-3. 2008
Albuminuria: a target for treatment of type 2 diabetic nephropathyDick de Zeeuw
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Ant Deusinglaan 1, 9713 AV Groningen, The Netherlands
Semin Nephrol 27:172-81. 2007....
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw
Department of Clinical Pharmacology, Groningen University Medical Center, Ant Deusinglaan 1, 9713 AV Groningen, Netherlands
Circulation 110:921-7. 2004..Albuminuria can be reduced with drugs that block the renin-angiotensin system (RAS). We questioned whether the short-term drug-induced change in albuminuria would predict the long-term cardioprotective efficacy of RAS intervention...
Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized ratsSimone Vettoretti
Department of Clinical Pharmacology, University Medical Center Groningen and Groningen Institute for Drug Exploration (GUIDE, University of Groningen, The Netherlands
J Hypertens 24:2215-23. 2006..Both systemic vascular changes might be restored by renoprotective treatment with ACE inhibitor...
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal functionFrank A Holtkamp
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Kidney Int 80:282-7. 2011..Hence, interpretation of trial results relying on slope-based GFR outcomes should separate the initial drug-induced GFR change from the subsequent long-term effect on GFR...
Gender differences in predictors of the decline of renal function in the general populationNynke Halbesma
Division of Nephrology, Department of Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Kidney Int 74:505-12. 2008..These studies show that there are gender differences in the standard predictors of the decline in renal function...
Does angiotensin (1-7) contribute to the anti-proteinuric effect of ACE-inhibitorsEls A Van der Wouden
Department of Clinical Pharmocology, Division of Nephrology, Groningen University Institute for Drug Exploration GUIDE, University Medical Center Groningen, Groningen, The Netherlands
J Renin Angiotensin Aldosterone Syst 6:96-101. 2005..We conclude that systemic Ang (1-7) plays no major role in the anti-proteinuric and BPlowering effects of ACE-I in this rat model of adriamycin-induced nephrosis...
Renal endothelial function and blood flow predict the individual susceptibility to adriamycin-induced renal damagePeter Ochodnicky
Department of Clinical Pharmacology, University Medical Center Groningen UMCG and Graduate School for Drug Exploration GUIDE, University of Groningen, The Netherlands
Nephrol Dial Transplant 24:413-20. 2009..Here we hypothesized that individual differences in endothelial function in vitro and renal perfusion in vivo predict the severity of renal damage in a model of adriamycin-induced nephropathy...
Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosisWillemijn A K M Windt
Department of Clinical Pharmacology, Groningen University, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
J Renin Angiotensin Aldosterone Syst 5:197-202. 2004..We compared the antiproteinuric efficacy of captopril to that of the captopril-lysozyme conjugate in adriamycin-induced proteinuric rats fed with a high-sodium diet...
Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic ratsHendrik Bos
Department of Nephrology, Groningen University, Groningen, The Netherlands
J Renin Angiotensin Aldosterone Syst 4:106-12. 2003..Renal ACE activity is a consistent marker of individual differences in proteinuria-associated renal damage: further studies are needed to investigate a possible pathogenetic role in renal damage...
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studiesWouter B A Eijkelkamp
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Hypertens 25:871-6. 2007....
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockersHiddo J Lambers Heerspink
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Kidney Int 82:330-7. 2012..This underscores the avoidance of excessive sodium intake, particularly in type 2 diabetic patients receiving ARB therapy...
A central body fat distribution is related to renal function impairment, even in lean subjectsSara Joan Pinto-Sietsma
Division of Nephrology, Department of Internal Medicine, University Hospital Groningen, Groningen, The Netherlands
Am J Kidney Dis 41:733-41. 2003..Whether this depends on fat distribution is not known. We hypothesize that in addition to overweight, fat distribution may be associated with renal function abnormalities...
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuriaFolkert W Asselbergs
Department of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands
Circulation 110:2809-16. 2004..In addition, fosinopril treatment was associated with a trend in reducing cardiovascular events. Treatment with pravastatin did not result in a significant reduction in urinary albumin excretion or cardiovascular events...
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trialWouter B A Eijkelkamp
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
J Am Soc Nephrol 18:1540-6. 2007..Antihypertensive treatment that is aimed at improving renal outcomes in patients with diabetic nephropathy may therefore require a dual strategy, targeting both SBP and albuminuria reduction...
C-reactive protein modifies the relationship between blood pressure and microalbuminuriaErik M Stuveling
Department of Medicine, University Medical Center, Groningen, The Netherlands
Hypertension 43:791-6. 2004..0004). No significant interactions between other risk factors and CRP with respect to the risk of microalbuminuria were encountered. Thus, CRP modifies the relation between blood pressure and microalbuminuria...
Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system interventionWillemijn A K M Windt
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Am Soc Nephrol 17:3059-66. 2006..VPI treatment seemed to provide no additional renoprotection compared with sole ACEi after 6 wk of treatment in this model, despite a more pronounced ACE-inhibiting effect of VPI...
The association between atherosclerotic risk factors and renal function in the general populationJacobien C Verhave
Department of Medicine, Division of Nephrology, Groningen University Medical Center, Groningen, The Netherlands
Kidney Int 67:1967-73. 2005..Some risk factors are associated with elevated filtration, some with an impaired filtration, and others with both a higher and a lower renal function...
Endothelial dysfunction and infarct-size relate to impaired EDHF response in rat experimental chronic heart failureSimone Gschwend
Department of Clinical Pharmacology, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands
Eur J Heart Fail 5:147-54. 2003..Inconsistent results have been obtained concerning the role of endothelial dilative mediators nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)...
Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan TrialYan Miao
Department of Clinical Pharmacology, University Medical Centre Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
Hypertension 58:2-7. 2011..These findings support the view that SUA may be a modifiable risk factor for renal disease...
Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized ratsWillemijn A K M Windt
Department of Clinical Pharmacology, Groningen Institute for Drug Evaluation, University Medical Center Groningen, University of Groningen, The Netherlands
Eur J Pharmacol 580:231-40. 2008..32, P=0.003). In conclusion, both pharmacodynamic and -kinetic factors account for the non-response to lisinopril. Whether these can be overcome simply by increasing drug dosage in non-responders should be investigated...
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trialsFrank A Holtkamp
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, Groningen, The Netherlands
Eur Heart J 32:1493-9. 2011....
Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational studyJaco Voorham
Department of Clinical Pharmacology, Department of Epidemiology, University Medical Center Groningen, University of Groningen, The Netherlands
Pharmacoepidemiol Drug Saf 19:1078-86. 2010..Assessment of quality of cardiometabolic risk management in diabetes in primary care...
An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trialsPaul A Smink
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Hypertens 30:1022-8. 2012..Treatment with the angiotensin receptor blocker (ARB) losartan lowers SUA in contrast to other ARBs. Whether reductions in SUA during ARB therapy are associated with cardiovascular protection is unclear. We aimed to investigate this...
Urinary albumin excretion as a predictor of the development of hypertension in the general populationAuke H Brantsma
Division of Nephrology, Department of Medicine, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB The Netherlands
J Am Soc Nephrol 17:331-5. 2006..In conclusion, these findings support the hypothesis that mild renal damage may precede the development of hypertension...
Endothelial function predicts the development of renal damage after combined nephrectomy and myocardial infarctionPeter Ochodnicky
Department of Clinical Pharmacology, University Medical Centre Groningen, The Netherlands
J Am Soc Nephrol 17:S49-52. 2006..Further exploration of the underlying mechanisms may lead to discovery of preventive renoprotective therapies...
Comparison of different measures of urinary protein excretion for prediction of renal eventsHiddo J Lambers Heerspink
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Am Soc Nephrol 21:1355-60. 2010..In conclusion, measurement of the albumin:creatinine ratio in a first-morning void is the superior method to predict renal events in patients with type 2 diabetes and nephropathy...
Uptake of angiotensin II receptor blockers in the treatment of hypertensionJacoba P Greving
Department of Clinical Pharmacology, University Medical Center Groningen, PO Box 196, 9700, AD, Groningen, The Netherlands
Eur J Clin Pharmacol 61:461-6. 2005..To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial and second-line treatment of hypertension...
Renal and cardio-protective effects of direct renin inhibition: a systematic literature reviewHiddo J Lambers Heerspink
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Hypertens 27:2321-31. 2009..This systematic review aims to delineate the effects of DRIs on surrogate markers of renal and cardiovascular function...
What predicts progression and regression of urinary albumin excretion in the nondiabetic population?Auke H Brantsma
Division of Nephrology, Department of Medicine, University Medical Center Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
J Am Soc Nephrol 18:637-45. 2007....
Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohortGrigory Sidorenkov
Department of Clinical Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Med Care 51:172-9. 2013..Performance measures are used for assessing quality of care. Higher performance shown by these measures is expected to reflect better care, but little is known whether they predict better patient outcomes...
Impact of the preintervention rate of renal function decline on outcome of renoprotective interventionA Titia Lely
Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, Netherlands
Clin J Am Soc Nephrol 3:54-60. 2008..There are no data showing that this provides groups with similar baseline rates of renal function loss. Accordingly, the impact of preintervention rate of renal function loss (slope) on outcome of studies has not been established...
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?Liffert Vogt
Division Nephrology, Department of Medicine, Groningen University Medical Center, Groningen, The Netherlands
J Am Soc Nephrol 16:S53-7. 2005..To further improve renoprotective treatment strategies, it is important to explore other modes of antiproteinuric intervention in patients with residual proteinuria during RAS blockade...
Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinaprilBart Westendorp
Department of Clinical Pharmacology, University of Groningen, The Netherlands
Eur J Heart Fail 7:1085-94. 2005..Therefore, we investigated whether hydrochlorothiazide (HCTZ) or dietary sodium restriction further improves survival in ACEi-treated rats with MI...
Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damagePeter Ochodnicky
Department of Clinical Pharmacology, University Medical Center Groningen and Groningen Institute for Drug Exploration GUIDE, University of Groningen, The Netherlands
J Cardiovasc Pharmacol 47:S151-62; discussion S172-6. 2006..In near future, dietary components improving nitric oxide bioavailability, such as cocoa-derived flavanols may play important role in these preventive strategies...
Myocardial infarction does not further impair renal damage in 5/6 nephrectomized ratsWillemijn A K M Windt
Department of Clinical Pharmacology, University Medical Center Groningen, PO Box 196, NL 9700 AD, Groningen, The Netherlands
Nephrol Dial Transplant 23:3103-10. 2008..The effects of an MI on pre-existing severe renal function loss and the effects of RAAS intervention interrupting this hypothesized cardiorenal interaction are however unknown and clinically even more relevant...
Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interactionRichard P E van Dokkum
Department of Clinical Pharmacology, University Medical Center Groningen, Antonius Deusinglaan 1, NL 9713 AV Groningen, The Netherlands
J Am Soc Nephrol 15:3103-10. 2004..Finding the underlying mechanism will enable improved protection for both kidneys and heart...
Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized ratSimone Gschwend
Department of Clinical Pharmacology, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, The Netherlands
J Am Soc Nephrol 13:2909-15. 2002..This study demonstrates for the first time that individual renal endothelial dilatory function of the healthy rat predicts susceptibility to renal damage after 5/6 Nx, which seems to depend on individual endothelial NO and PG activity...
Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic ratMarijke Haas
Department of Clinical Pharmacology, Groningen University Institute for Drug Exploration, University of Groningen, P.O. Box 196, NL-9700 AD Groningen, The Netherlands
Clin Sci (Lond) 105:51-7. 2003..Taken together, the data suggest that proteinuria is toxic for the proximal tubular cells and that ACE inhibition protects the remaining functional tubular cells directly against destruction through decreasing hypercatabolism...
Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric ratsLeo E Deelman
Department of Clinical Pharmacology, University of Groningen, Groningen, 9713AV, The Netherlands
J Renin Angiotensin Aldosterone Syst 4:38-42. 2003..In conclusion, renal expression of ACE, AT2-R, and AT1-R mRNA is not mediated by protein leakage. Local intrarenal protein leakage did influence renal TGF-beta mRNA expression...
Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort studyJaco Voorham
Department of Clinical Pharmacology, Faculty of Medical Science, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
PLoS ONE 7:e38707. 2012..We hypothesized that these effects differ according to expected priority of the conditions...
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw
Department of Clinical Pharmacology, University Medical Center Groningen, Groningen, The Netherlands
Kidney Int 65:2309-20. 2004....
Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarctionBart Westendorp
Department of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands
J Renin Angiotensin Aldosterone Syst 5:27-32. 2004..In line with the latter, the aim of the present study was to explore whether dietary sodium restriction enhances the efficacy of ACE-I after MI...
Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortalityHiddo J Lambers Heerspink
Department of Clinical Pharmacology, University Medical Center Groningen, P O Box 30 001, 9700 RB Groningen, The Netherlands
Am J Epidemiol 168:897-905. 2008..To predict cardiovascular morbidity and all-cause mortality, measuring ACR in a first-morning-void urine sample is a good alternative to measuring 24-hour UAE...
First morning voids are more reliable than spot urine samples to assess microalbuminuriaElsbeth C Witte
Department of Nephrology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
J Am Soc Nephrol 20:436-43. 2009..In conclusion, measurement of albuminuria in a first morning void, preferably as the ACR, is more reliable than a spot urine sample to diagnose and monitor microalbuminuria...
Screening for albuminuria identifies individuals at increased renal riskMarije van der Velde
Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands
J Am Soc Nephrol 20:852-62. 2009..Screening for albuminuria identifies patients at increased risk for progressive renal disease, 40 to 50% of whom were previously undiagnosed or untreated...
Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?Stephan J L Bakker
Department of Internal Medicine, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Curr Hypertens Rep 11:111-7. 2009....
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general populationGerard C M Linssen
Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Hanzeplein 1, PO Box 30 001, 9700 RB Groningen, The Netherlands
Eur Heart J 31:120-7. 2010..However, their prognostic value in the general population is less well established. The purpose of our study was to investigate the prognostic properties of NT-proBNP for death and cardiovascular (CV) events in the general population...
Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathyLiffert Vogt
University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Hypertension 55:1206-9. 2010..These results question whether urotensin receptor antagonism represents a new treatment strategy in this high-risk patient population...
Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetesAuke H Brantsma
Division of Nephrology, Department of Medicine, University Medical Center Groningen, P.O. Box 30, 001, 9700 RB, Groningen, Netherlands
Diabetes Care 28:2525-30. 2005..CONCLUSIONS: UAE predicts type 2 diabetes independent of the metabolic syndrome and other known risk markers of development of type 2 diabetes. The predictive value of UAE was modified by the level of CRP...
Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?Hendrik Bos
Department of Clinical Pharmacology, Faculty of Medical Sciences and Groningen University Institute of Drug Exploration GUIDE, University of Groningen, The Netherlands
Nephrol Dial Transplant 17:793-7. 2002..In the present study we therefore investigated whether the severity of systemic nephrosis, estimated from plasma cholesterol, predicts residual proteinuria during ACE inhibition...
Dual renin-angiotensin system blockade at optimal doses for proteinuriaGozewijn D Laverman
Division of Nephrology, Faculty of Medical Sciences, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Kidney Int 62:1020-5. 2002..The antiproteinuric effect of combining the angiotensin-converting enzyme (ACE) inhibitor lisinopril and the angiotensin II (Ang II) antagonist losartan was compared to that of the optimal antiproteinuric doses of monotherapy...
The abnormal renal vasodilator response to D1-like receptor stimulation in conscious SHR can be normalized by AT1 blockadeP A Marcel de Vries
Departments of Clinical Pharmacology, Groningen University Institute for Drug Exploration GUIDE, State University, Groningen, The Netherlands
J Cardiovasc Pharmacol 44:571-6. 2004....
Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakesGozewijn D Laverman
Department of Medicine, Groningen University Institute of Drug Exploration GUIDE, University of Groningen, The Netherlands
Kidney Int 63:64-71. 2003..Therefore, in contrast with ACEI, VPI may be effective during high sodium intake...
Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartanLiffert Vogt
Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
J Am Soc Nephrol 19:999-1007. 2008..Combining these interventions in sodium status is an effective method to maximize the antiproteinuric efficacy of RAAS blockade...
Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in ratsR Folgert G Haverdings
Department of Pharmacokinetics and Drug Delivery, University of Groningen, The Netherlands
Br J Pharmacol 136:1107-16. 2002..5 These data demonstrate that intravenous administration of a captopril-lysozyme conjugate leads to more selective renal ACE inhibition and enhanced renal effects as well as less systemic effects compared to captopril itself...
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretionAuke H Brantsma
Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands
Nephrol Dial Transplant 23:3851-8. 2008..In this study we evaluated cardiovascular and renal outcome in subjects with stage 1 and 2 CKD. For comparison, we also studied these outcomes in stage 3 CKD...
The role of angiotensin(1-7) in renal vasculature of the ratEls A Van der Wouden
Department of Clinical Pharmacology, Groningen University Institute for Drug Exploration, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
J Hypertens 24:1971-8. 2006..CONCLUSION: Angiotensin(1-7) antagonizes angiotensin II in renal vessels in vitro, but does not appear to have a major function in normal physiological regulation of renal vascular function in vivo...
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screeningNynke Halbesma
Division of Nephrology, Department of Medicine, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands
J Am Soc Nephrol 17:2582-90. 2006..However, macroalbuminuria is a better risk marker than low eGFR or erythrocyturia to identify in population screening of individuals who are at risk for accelerated GFR loss...
Low sodium diet inhibits the local counter-regulator effect of angiotensin-(1-7) on angiotensin IIAnton J M Roks
Department of Clinical Pharmacology, Groningen University Institute for Drug Exploration GUIDE, University of Groningen, Groningen, The Netherlands
J Hypertens 22:2355-61. 2004..The role of angiotensin receptor subtypes and the endothelium was assessed...
Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometryJacoline W Brinkman
Department of Clinical Pharmacology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
Clin Chem 53:1520-6. 2007..We investigated whether this technique is affected by sample temperature, particularly freezing...
Low sodium modifies the vascular effects of angiotensin-converting enzyme inhibitor therapy in healthy ratsMenno J A Kocks
Department of Clinical Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
J Pharmacol Exp Ther 310:1183-9. 2004..These findings provide a rationale for further studies addressing the mechanism-of-actions of our therapies to find additional strategies to improve therapy response...
Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosisHendrik Bos
Department of Clinical Pharmacology, Faculty of Medical Sciences and Groningen University Institute of Drug Exploration (GUIDE, University of Groningen, Groningen, The Netherlands
Kidney Int 61:473-80. 2002..Thus, in established adriamycin nephrosis, blockade of the renin-angiotensin system at two different levels offers no additional benefit over ACE inhibition alone, either on the group or individual level...
Update on microalbuminuria as a biomarker in renal and cardiovascular diseaseHiddo J Lambers Heerspink
Department of Clinical Pharmacology, The Netherlands bDepartment of Internal Medicine, The Netherlands
Curr Opin Nephrol Hypertens 15:631-6. 2006..To discuss recently published papers on the potential use of albuminuria as a predictor of cardiovascular and renal disease...
Renoprotective therapy: is it blood pressure or albuminuria that matters?Paul E de Jong
Division of Nephrology, Department of Medicine, University Medical Center Groningen, 9713 GZ Groningen, Netherlands
Lancet 365:913-4. 2005
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trialLiffert Vogt
Department of Clinical Pharmacology and Internal Medicine, Division of Nephrology, University Medical Center, University of Groningen, The Netherlands
J Hypertens 23:2055-61. 2005....
Best practice for hypertensive patients with kidney diseaseDick de Zeeuw
Department of Clinical Pharmacology, University of Groningen, Ant Deusingglaan 1, 9713 AV Groningen, The Netherlands
Hosp Med 64:96-100. 2003..The US National Kidney Foundation guidelines recommend that angiotensin-converting enzyme inhibitors and angiotensin type receptor antagonists are first choice therapy for these patients...
Targeting of doxorubicin to the urinary bladder of the rat shows increased cytotoxicity in the bladder urine combined with an absence of renal toxicityMarijke Haas
University of Groningen, The Netherlands
J Drug Target 10:81-9. 2002..A release of cytotoxic doxorubicin in the urinary bladder can be achieved by acidification of the urine. This technology, after further optimization, may provide an interesting tool for the treatment of bladder carcinoma...
Renoprotection: a matter of blood pressure reduction or agent-characteristics?Liffert Vogt
Department of Internal Medicine, Division of Nephrology, University Hospital, Groningen, The Netherlands
J Am Soc Nephrol 13:S202-7. 2002..Future studies should further explore the renoprotective benefit of non-antihypertensive intervention measures, alone and in combination with antihypertensive strategies...
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general populationHans L Hillege
Trial Coordination Center, Department of Cardiology, University Hospital of Groningen, Groningen, The Netherlands
Circulation 106:1777-82. 2002..The excess risk was more attributable to death from CV causes, independent of the effects of other CV risk factors, and the relationship was already apparent at levels of albuminuria currently considered to be normal...
Does comorbidity explain trends in prescribing of newer antihypertensive agents?Jacoba P Greving
Department of Clinical Pharmacology, University of Groningen, The Netherlands
J Hypertens 22:2209-15. 2004..The association between comorbidity and trends in prescribing of angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor blockers (ARBs) was examined for the period 1996-2000...
Cardiovascular risk factors are differently associated with urinary albumin excretion in men and womenJacobien C Verhave
Division of Nephrology, Department of Medicine, University Medical Center Groningen, Groningen University Institute of Drug Exploration (GUIDE, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
J Am Soc Nephrol 14:1330-5. 2003..It is concluded that gender differences exist in the association between cardiovascular risk factors and UAE. This is consistent with a larger vascular susceptibility to these risk factors in men as compared with women...
Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal functionJacobien C Verhave
Division of Nephrology, Department of Medicine, University Medical Center, Groningen, The Netherlands
J Am Soc Nephrol 15:1316-22. 2004..For studying the relation of risk factors and renal function in large population studies, indirect estimates of renal function should be used with caution...
Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factorsAkin Ozyilmaz
Division of Nephrology, Department of Medicine, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
Nephrol Dial Transplant 25:3560-8. 2010..As albuminuria is easy to measure, we tested whether a screening approach in which detailed risk factor measurement is done only after selection of subjects with an elevated albuminuria results in a higher yield of subjects at risk...
initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trialMerel E Hellemons
Department of Clinical Pharmacology, University ofGroningen, Groningen, The Netherlands
Diabetes Care 34:2078-83. 2011....
Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?Stephan J L Bakker
Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Curr Hypertens Rep 7:379-84. 2005....
Physicians' attitudes towards treatment guidelines: differences between teaching and nonteaching hospitalsJacoba P Greving
Department of Clinical Pharmacology, University Medical Center Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands
Eur J Clin Pharmacol 62:129-33. 2006..To investigate whether physicians' attitudes towards treatment guidelines for primary and secondary care differ between teaching and nonteaching hospitals shortly before and 4 years after the guidelines' introduction...
High dietary sodium blunts affects of angiotensin-converting enzyme inhibition on vascular angiotensin I-to-angiotensin II conversion in ratsMenno J A Kocks
Department of Internal Medicine, Division of Nephrology, University of Groningen, The Netherlands
J Cardiovasc Pharmacol 42:601-6. 2003..Thus, HS blunts the ACEi-induced reduction of functional vascular Ang I conversion compared with LS. Whether the blunted functional vascular conversion is causally related to the blunted blood pressure response remains to be elucidated...
Immune modulation and graft protection by gene therapy in kidney transplantationMaria Sandovici
Department of Clinical Pharmacology, Faculty of Medical Sciences, University Medical Center Groningen, The Netherlands
Eur J Pharmacol 585:261-9. 2008..In this article, we give an overview of the current state of gene therapy in experimental models of kidney transplantation...
Screening and monitoring for albuminuria: the performance of the HemoCue point-of-care systemHiddo J Lambers Heerspink
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Kidney Int 74:377-83. 2008....
Is the randomized controlled drug trial in Europe lagging behind the USA?Hiddo J Lambers Heerspink
Department of Clinical Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
Br J Clin Pharmacol 66:774-80. 2008..The purpose of this study was to benchmark Europe's position on drugRCTs relative to the rest of the world, and to identify factors that may drive this performance...
Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic responsePeter Ochodnicky
Department of Clinical Pharmacology, University Medical Center Groningen UMCG and Groningen Institute for Drug Exploration GUIDE, University of Groningen, Groningen, The Netherlands
J Nephrol 19:246-58. 2006..Therefore, a specific manipulation of renal and systemic ED might provide benefits in various stages of CKD. ED thus may represent an ideal therapeutic target not only for treatment, but also for primary prevention of renal disease...
Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial resultsGiuseppe Remuzzi
Clinical Research Center for Rare Diseases Aldo e Cele Dacc, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy
J Am Soc Nephrol 15:3117-25. 2004..Angiotensin II antagonism is a suitable and well-tolerated treatment for individuals with type 2 diabetes even with GFR levels approaching renal replacement therapy...
Biochemical risk markers: a novel area for better prediction of renal risk?Erik M Stuveling
Nephrol Dial Transplant 20:497-508. 2005
Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuriaAdrienne A M Zandbergen
Department of Internal Medicine, Erasmus University Medical Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands
Diabetes Care 30:3119-21. 2007
Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intakeFrank G H van der Kleij
Groningen University Institute for Drug Exploration, University Hospital, Hanzeplein 1, P O Box 30 001, 9700 RB Groningen, The Netherlands
J Am Soc Nephrol 13:1025-33. 2002..These results support the presence of gene-environment interactions between ACE genotypes and dietary sodium intake...
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patienAndrew J Palmer
CORE Center for Outcomes Research, Buendtenmattstrasse 40, 4102 Binningen Basel, Switzerland
Diabetes Care 27:1897-903. 2004..The aim of this study was to determine the most cost-effective time point for initiation of irbesartan treatment in hypertensive patients with type 2 diabetes and renal disease...
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurementEric L Knight
Channing Laboratory, Renal Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Kidney Int 65:1416-21. 2004....
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysisTazeen H Jafar
New England Medical Center, Tufts University School of Medicine, Boston, MA, USA
Nephrol Dial Transplant 18:2047-53. 2003..Therefore, we undertook this analysis to explore the independent association of renal disease progression with gender...
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysisTazeen H Jafar
Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 139:244-52. 2003..0 g/d. Systolic blood pressure less than 110 mm Hg may be associated with a higher risk for kidney disease progression...
Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with Type 2 diabetesMaarten J Postma
Groningen University Institute for Drug Exploration University of Groningen Research Institute of Pharmacy GUIDE GRIP, Department of Social Pharmacy, Pharmaco epidemiology and Pharmacotherapy, The Netherlands
Expert Opin Pharmacother 4:1543-50. 2003..In particular, potential pharmacoeconomic implications and related methodological aspects of the recent RENAAL trial for losartan are considered...
Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trialAdrienne A M Zandbergen
Department of Internal Medicine, Ikazia Hospital and Erasmus University Medical Centre, Rotterdam, The Netherlands
Ann Intern Med 139:90-6. 2003..The effect of angiotensin-receptor antagonists in normotensive diabetic patients with microalbuminuria has not yet been reported...
A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertensionAndrew J Palmer
CORE Center for Outcomes Research, Allschwil Basel, Switzerland
Curr Med Res Opin 22:2095-100. 2006..We performed a cost-consequence analysis in a French setting of the renoprotective benefit of irbesartan in hypertensive type 2 diabetes patients over a 25-year period...
